The dataset generated and analyzed during the current study is not publicly available because this could compromise participant privacy and consent. The data contains very sensitive and vulnerable information related to men who have sex with men. The participants have agreed to the use of their data for scientific publications only. Data are available for interested researchers from Xinjiang Medical University First Affiliated Hospital Ethics Committee for researchers who meet the criteria for access to confidential data (Miss Shen Jie, email: <shenjie_job@sina.cn>). Additionally, interested researchers may obtain parts of data by sending a data request email to correspondence author on reasonable purpose (Prof. Dai Jianghong, Email address: <epi102@sina.com>).

Introduction {#sec005}
============

Human papillomavirus (HPV) is the most common sexually transmissible infectious agent worldwide \[[@pone.0187928.ref001]\]. So far, more than 200 types of HPV have been identified, and around 40 of these infect the squamous epithelium of the genital tract including the anus, cervix, vulva and vagina \[[@pone.0187928.ref002]\]. Importantly, most of HPV infections are transient and asymptomatic, since they are rapidly cleared by an intact immune system. However, in some instances, HPV may cause clinical manifestations of variable severity, spanning from benign warts (condylomata), mainly caused by the low-risk HPV 6 and 11, to cancerous lesions, caused by high-risk (HR) types (e.g. HPV 16 and 18) \[[@pone.0187928.ref003]\]. HR-HPV infection was thought to be responsible for 7--8% of all human malignancies \[[@pone.0187928.ref004]\] and was associated with majority of cervical cancers, anal cancers, vaginal cancers, vulvar cancers, and oropharyngeal carcinomas \[[@pone.0187928.ref005]\].

Recently, the interest on the burden of anal HPV infection has been growing because of increasing incidence of anal cancers among some at-risk population such as men who have sex with men (MSM) and HIV-infected individuals. Due to their sexual habits, MSM show a particularly high prevalence of HPV in the anal canal and develop lesions at this body site more frequently than any other population \[[@pone.0187928.ref006]\]. The prevalence of anal HPV infection among MSM was inconsistently reported in previous studies \[[@pone.0187928.ref007]\]. Prevalence of anal HPV infection among HIV-positive MSM in China was well documented \[[@pone.0187928.ref008]--[@pone.0187928.ref011]\]; however, data on prevalence of anal HPV among HIV-negative MSM, particularly in Northwestern China where reported number of MSM was increasing, was scarce. A better understanding of anal HPV infection among MSM may help inform strategies for the prevention of anal cancer in this population. In this study, we aimed to find out the prevalence and predictors of anal HPV infection among HIV-negative MSM in Urumqi city, China.

Materials and methods {#sec006}
=====================

Ethical statement {#sec007}
-----------------

Xinjiang Medical University First Affiliated Hospital Ethics Committee reviewed and approved this study. Written informed consent obtained from each study participant before the interview and testing. All private information from questionnaire were kept confidential and used for population analysis only.

Study population {#sec008}
----------------

We performed a cross-sectional study of HPV prevalence using anal swab specimens among HIV-negative MSM in Urumqi city of Xinjiang, China between April 1^st^ and October 30^th^ in 2016. Participants were recruited, through local non-government organization (Tianshan Volunteers Workstation), using the methods of website advertisement, WeChat group (Chinese social media mobile application software), MSM bars, sexually transmitted disease clinics, and voluntary HIV counseling and testing clinics. Additionally, those recruited were also encouraged to refer their peers to attend the study. Potential participants were invited to Tianshan Volunteers Workstation for questionnaire interview, HPV swabs, and HIV testing during the study period. Participants were eligible if they were male and at least 18 years old, self-reported having sex with men in the past year, were willing to provide anal swab specimens for HPV testing and blood for HIV testing, and were able to provide written informed consent. All participants were compensated 30 Chinese yuan (approximately four and half US dollar).

Data collection {#sec009}
---------------

Data were collected using a questionnaire administered by trained interviewers who were also MSM in a private room. The questionnaire included information on socio-demographic characteristics (e.g. age group, ethnicity, education level, marital status, etc.), self-reported sexual orientation, heterosexual behavior in the past year, experience of anal intercourse in the past year, sexual role, commercial sex experience, circumcision status, STD infection in the past year, smoking status, and alcohol consumption.

Specimen collection and laboratory testing {#sec010}
------------------------------------------

Human immunodeficiency virus infection status was determined by an enzyme immunoassay (Wantai Biological Pharmacy, Beijing, China) and was confirmed by HIV-1/2 Western blot assay (HIV Blot 2.2 WB; Genelabs Diagnostics, Singapore, Singapore).

Trained physician collected anal samples by inserting a saline water moistened nylon flocked swab 3--5cms in the anal canal and gently rotating it for about 2 minutes. The swab was then kept in 3 mL of sample transport medium for Hybribio 37 HPV GenoArray Diagnostic Kit (Hybribio Biotech Limited Corporation, Chaozhou, China). Hybribio 37 HPV GenoArray Diagnostic Kit Test is based on a flow-through hybridization and gene-chip method. The low-density gene chip was pre-fixed with 37 type-specific oligonucleotides and the genotype was analyzed using HybriMax (Hybribio Biotech Limited Corporation, Chaozhou, China).The final results were detected by colorimetric change on the membrane under direct visualization. Positive and negative controls were included in the GenoArray test kit in every PCR analysis as well as during the hybridization process for quality control. Mixtures of different specific probes can be used in the same well of a 42-well plate format allowing for multiplex analysis. Blue-purple spots were recognized as HPV positive. This testing kit can detect 37 common types of HPV, including 23 oncogenic or HR-HPV (16, 18, 26, 31, 33, 35,39, 45, 51, 52, 56, 58, 59, 66, 68, 82,83,53, 55, 34, 57, 69, and 71) and 14 non-oncogenic or LR-HPV (06, 11, 40, 42, 44, 54,61, 67, 70, 72, 73, 81, and 84). Study participants with genotyping positive for any HPV type were determined to be currently infected with HPV. The operating protocol has been described in detail elsewhere \[[@pone.0187928.ref012], [@pone.0187928.ref013]\].

Statistical analysis {#sec011}
--------------------

Questionnaires and laboratory results were entered using EpiData version 3.1(The Epi Data Association Odense, Denmark). Data were analyzed using SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). Unconditional univariate logistic regression models were used to evaluate the association between each variable and any anal HPV infection. Multivariate logistic regression was applied to determine predictors of any anal HPV infection. All variables with *p*-values\< 0.2 in univariate analyses were entered into the multivariate logistic model. Crude odds ratios (COR) and adjusted odds ratios (adjusted OR) were calculated, as appropriate along with 95% confidence intervals (CI).

Results {#sec012}
=======

Characteristics of study participants {#sec013}
-------------------------------------

538 potential participants were invited for interview, HPV swabs and HIV testing. 16 did not give written consent, 12 did not provide blood for HIV testing, and eight did not show up at study site. Therefore, 502 individuals were recruited and two were positive for HIV. Finally, only data of 500 eligible HIV-negative participants were analyzed. Of them, 250 (50.0%) were aged≤ 29 years old, 277 (55.4%) were local residents, 457(91.4%) were of Han ethnicity, and 258(51.6%) had received education at the high school level or lower. In addition, 108 (21.6%) reported having sex with women in the past year, 439(87.8%) reported experience of anal intercourse in the past six months, 185 (37.0%) reported having been circumcised, only 44 (8.8%) reported having had STDs in the past year, and only 17 (3.4%) reported experience of commercial sex in the past year.

Prevalence of HPV infection {#sec014}
---------------------------

The genotyping results of anal HPV were available for all participants ([Table 1](#pone.0187928.t001){ref-type="table"}). Of them, 259 (51.8%) were positive for at least one of the targeted 37 HPV genotypes. All were negative for HPV 26, HPV 35, HPV 71, HPV 40 and HPV 67. Among those positive for any 37 HPV genotypes, 118(45.6%) were exclusively infected with HR-HPV, 69(26.6%) were exclusively infected with LR-HPV, and 72 (27.8%) were infected with both LR-HPV and HR-HPV. Among those exclusively infected with HR-HPV, 29.7% were multiple infections, while it was 13.0% among those with exclusively infected with LR-HPV.HPV 16 (11.2%) and HPV51 (7.0%) were found to be the most prevalent HR-HPV genotypes; HPV6 (11.8%) and HPV11 (10.8%) were the most prevalent LR-HPV genotypes. The prevalence of 2-valent, quadrivalent and 9-valent HPV vaccine genotypes among participants all tested for HPV were 15.0%, 31.0% and 38.2%, respectively. However, among those infected with at least one of the targeted 37 anal HPV genotypes, 75(29.0%), 155(59.8%) and 191(73.7%) were infected with 2-valent, quadrivalent and 9-valent HPV vaccine-covered genotypes.

10.1371/journal.pone.0187928.t001

###### HPV detection and genotyping among 500 HIV-negative MSM.

![](pone.0187928.t001){#pone.0187928.t001g}

  HPV genotype                         N     \%
  ------------------------------------ ----- ------
  **Exclusively HR-HPV infection**     118   23.6
      Single infection                 83    70.3
      Multiple infection               35    29.7
  **Exclusively LR-HPV infection**     69    13.8
      Single infection                 60    87.0
      Multiple infection               9     13.0
  **HR-HPV/LR-HPV coinfection**        72    14.4
  **HR-HPV types**                           
      HPV16                            56    11.2
      HPV51                            35    7.0
      HPV18                            27    5.4
      HPV58                            25    5.0
      HPV33                            23    4.6
      HPV 39                           27    5.4
      HPV 31                           13    2.1
      HPV 45                           7     1.4
      HPV 52                           13    2.6
      HPV 56                           5     1.0
      HPV 59                           7     1.4
      HPV 66                           12    2.4
      HPV 68                           12    2.4
      HPV 82                           5     1.0
      HPV 83                           8     1.6
      HPV 53                           13    2.6
      HPV 55                           3     0.9
      HPV 34                           2     0.4
      HPV 57                           0     0
      HPV 69                           3     0.6
  **LR-HPV types**                           
      HPV6                             59    11.8
      HPV11                            54    10.8
      HPV61                            18    3.6
      HPV84                            14    2.8
      HPV 42                           1     0.2
      HPV 54                           9     1.8
      HPV 70                           6     1.2
      HPV 73                           6     1.2
      HPV 44                           1     0.2
      HPV 72                           1     0.2
      HPV 81                           9     1.8
  **2-valent HPV vaccine types**       75    15.0
  **Quadrivalent HPV vaccine types**   155   31.0
  **9-valent HPV vaccine types**       191   38.2

Notes: HPV, human papillomavirus; MSM, men who have sex with men; HR-HPV, high risk HPV; LR-HPV, low risk HPV. 2-valent HPV vaccine types refer to HPV-16/18; Quadrivalent HPV vaccine types refer to HPV -6/11/16/18; 9-valent HPV vaccine types refer to HPV-6/11/16/18/31/33/45/52/58

Risk factors associated with HPV infections {#sec015}
-------------------------------------------

Univariate and multivariate logistic regression analyses were performed to assess the associations between variables and any HPV infection among HIV-negative MSM. Multivariate logistic regression analysis indicated that receptive anal intercourse in the past year was the only predictor of any anal HPV infection ([Table 2](#pone.0187928.t002){ref-type="table"} and [Table 3](#pone.0187928.t003){ref-type="table"}).

10.1371/journal.pone.0187928.t002

###### Characteristics of 500 study participants and univariate analysis of association between variables and any anal HPV infection \[n (%)\].

![](pone.0187928.t002){#pone.0187928.t002g}

  Characteristics                                                              N     Any HPV infection   COR         *P* value           
  ---------------------------------------------------------------------------- ----- ------------------- ----------- ------------------- -------
  Age group (years)                                                                                                                      
      ≤29                                                                      250   129(49.8)           121(50.2)   0.87 (0.54--1.42)   0.575
      30--39                                                                   161   81(50.3)            80(49.7)    0.83(0.49--1.39)    0.472
      ≥40                                                                      89    49(55.1)            40(44.9)    Ref.                
  Ethnicity                                                                                                                              
      Han                                                                      457   231(50.5)           226(49.5)   Ref.                
      Others                                                                   43    28(65.1)            15(34.9)    1.83(0.95--3.51)    0.068
  Education level                                                                                                                        
      High school or lower                                                     258   138(53.5)           120(46.5)   1.11(0.81--1.63)    0.435
      University or higher                                                     242   121(50.0)           121(50.0)   Ref.                
  Marital status                                                                                                                         
      Unmarried                                                                369   198(53.7)           171(46.3)   1.30 (0.64--2.63)   0.462
      Married                                                                  97    45(46.4)            52(53.6)    0.97 (0.45--2.13)   0.947
      Divorced/widowed                                                         34    16(47.1)            18(52.9)    Ref.                
  Self-reported sexual orientation                                                                                                       
      Homosexual                                                               383   197(51.4)           186(48.6)   0.94 (0.62--1.42)   0.768
      Bisexual/heterosexual                                                    117   62(53.0)            55(47.0)    Ref.                
  Ever had sex with women in the past six month                                                                                          
      No                                                                       392   207(52.8)           185(47.2)   1.21 (0.79--1.85)   0.391
      Yes                                                                      108   52(48.1)            56(51.9)    Ref.                
  Number of male sexual partners in the past six months                                                                                  
      0                                                                        25    9(36.0)             16(64.0)    Ref.                
      1--4                                                                     403   205(50.9)           198(40.1)   1.84(0.79--4.26)    0.154
      ≥ 5                                                                      72    45(62.5)            27(37.5)    2.96(1.15--7.63)    0.024
  Frequency of condom use during homosexual behaviors in the past six months                                                             
      Never                                                                    44    22(50.0)            22(50.0)    1.01(0.54--1.91)    0.966
      Sometimes                                                                170   95(55.9)            75(44.1)    1.29(0.88--1.88)    0.198
      Always                                                                   286   142(49.7)           144(50.3)   Ref                 
  Experience of anal intercourse in the past six months                                                                                  
      Yes                                                                      439   231(52.6)           208(47.4)   1.31(0.77--2.24)    0.325
      No                                                                       61    28(45.9)            33(54.1)    Ref.                
  Pattern of anal intercourse in the past year                                                                                           
      Mainly receptive                                                         254   148(58.3)           106(41.7)   1.70(1.19--2.42)    0.003
      Mainly insertive                                                         246   111(45.1)           135(54.9)   Ref.                
  Experience of commercial sex in the past year                                                                                          
      Yes                                                                      17    12(70.6)            5(29.4)     2.29 (0.80--6.61)   0.115
      No                                                                       483   247(51.1)           236(48.9)   Ref.                
  Circumcision                                                                                                                           
      Yes                                                                      185   101(54.5)           84(45.6)    1.19(0.82--1.79)    0.362
      No                                                                       315   158(50.2)           157(49.8)   Ref.                
  Ever had STDs in the past year                                                                                                         
      Yes                                                                      44    25(56.8)            19(43.2)    1.25(0.67--2.33)    0.485
      No                                                                       456   234(51.3)           22(48.7)    Ref.                
  Smoking status                                                                                                                         
      Non-smokers                                                              220   115(52.3)           105(47.7)   1.02(0.72--1.44)    0.851
      Previous and current smokers                                             280   144(51.4)           136(48.6)   Ref.                
  Alcohol consumption                                                                                                                    
      No                                                                       359   187(52.1)           172(47.9)   1.02 (0.52--1.30)   0.399
      Yes                                                                      141   72(51.1)            69(48.9)    Ref.                

Notes: HPV, human papillomavirus; COR, crude odds ratio; STDs, sexual transmitted diseases.

10.1371/journal.pone.0187928.t003

###### Multivariate analysis of risk factors for any HPV infection.

![](pone.0187928.t003){#pone.0187928.t003g}

  Variables                                                                   Adjusted OR         *P* value   
  --------------------------------------------------------------------------- ------------------- ----------- --
  Ethnic group                                                                                                
      Han                                                                     Ref.                            
      Others                                                                  1.84(0.95--3.56)    0.072       
  Experience of commercial sex in the past year                                                               
      Yes                                                                     2.46 (0.83--7.30)   0.104       
      No                                                                      Ref.                            
  Pattern of anal intercourse in the past year                                                                
      Mainly receptive                                                        1.75 (1.22--2.51)   0.003       
      Mainly insertive                                                        Ref.                            
  Number of male sexual partners in the past six month                                                        
      0                                                                       Ref.                            
      1--4                                                                    1.71(0.72--4.05)    0.222       
      ≥ 5                                                                     2.10(0.84--5.27)    0.115       
  Frequency of condom use during homosexual behaviors in the past six month                                   
      Never                                                                   1.10(0.57--2.12)    0.775       
      Sometimes                                                               1.31(0.65--2.61)    0.452       
      Always                                                                  Ref.                            

Notes: HPV, human papillomavirus; OR, odds ratio

Discussion {#sec016}
==========

In this study, we investigated the prevalence of anal HPV infection among HIV-negative MSM in Urumqi city of Xinjiang province. The prevalence of any anal HPV infection among HIV-negative MSM in our study was 51.8%, which was within the range of results reported by various studies in China (33.8%-62.8%) \[[@pone.0187928.ref010], [@pone.0187928.ref011], [@pone.0187928.ref013]--[@pone.0187928.ref014]\]. However, it was lower than studies conducted in other countries (70%-85.3%) \[[@pone.0187928.ref015]--[@pone.0187928.ref018]\]. The discrepancy between these studies might be due to different characteristics of target population (e.g. source of recruitment, whether community-based or clinics, demographic characteristics, behavioral factors) or the HPV testing methods. Hybrid Capture and polymerase chain reaction (PCR)-based assays (e.g. Linear Array, MY09/11, GP5+/6+, etc.) were widely used for HPV detection and genotyping in epidemiological studies \[[@pone.0187928.ref018]\]. FDA-approved Hybrid Capture 2 system can detect five LR-genotypes and 13 HR-genotypes, but it only distinguishes between the high-risk and low-risk groups and does not permit identification of specific HPV genotypes \[[@pone.0187928.ref019]\]. Additionally, the detection limit of approximately 5000 genome equivalents makes it less sensitive than PCR\[[@pone.0187928.ref020]\].The sensitivity and specificity of PCR-based assays may be varied due to choice of primers, size of PCR products, and methods of sequence-analysis of PCR products. In addition, the number of HPV genotypes detected by PCR-based assays is varied as well \[[@pone.0187928.ref021]\]. PCR followed by flow-through hybridization and gene chip technology was used in our study, and its sensitivity, specificity, and number of HPV genotypes detected (37 genotypes) were quite similar to the popular PCR-based Linear Array assay \[[@pone.0187928.ref022],[@pone.0187928.ref023]\]. Therefore, comparison of anal HPV prevalence among MSM groups should be careful and cautious.

Approximately 90% of invasive anal cancers are attributed to single infections with a HR-HPV type \[[@pone.0187928.ref024]\]. Of HPV-positive anal cancers, the great majority are associated with HPV 16 type (85%), followed by HPV 18 (7%), with a combined HPV 16 and HPV 18 prevalence of 90% irrespective of geographic location \[[@pone.0187928.ref025]\].Therefore, screening for anal HR-HPV infection and HPV-related anal lesions may help to reduce the burden of anal cancer in this high risk population \[[@pone.0187928.ref026]\]. In our study, the prevalence of any HR-HPV type among HIV-negative MSM was 38.0%; this was higher than the results reported among HIV-negative MSM in Netherlands (33.6%), Thailand (36.6%) and China (27.1%) \[[@pone.0187928.ref014], [@pone.0187928.ref027], [@pone.0187928.ref028]\], but it was lower than the results of a study conducted in three cities of China (48.2%) \[[@pone.0187928.ref010]\]. Furthermore, the most prevalent HPV genotype in anal canal in our study was HPV 6(11.8%), followed by HPV 16(11.2%), HPV 11(10.8%), HPV 51(7.0%) and HPV 18(5.0%). The distribution of HPV genotype in anal canal was similar to that reported in other studies in China \[[@pone.0187928.ref010],[@pone.0187928.ref014]\] and South Africa\[[@pone.0187928.ref015]\], but different from that reported in Thailand\[[@pone.0187928.ref029]\], in which the most common HPV types were HPV 16 (27%), HPV 58 (23%), HPV 51(18%), and HPV 39 (14%). These results implied HPV genotype distribution might be varied among different MSM groups, and thus understanding the distribution of HPV genotypes among local MSM may help to guide the introduction of proper HPV vaccine in the local MSM community.

It is noticeable that the great majority of HPV genotypes detected in our study were covered by both quadrivalent and 9-valent HPV vaccines. This implies a great number of HPV cases in MSM in Urumqi might be prevented by these two vaccines. However, until very recently 2-valent HPV vaccine became available in Chinese markets and it is the only available HPV vaccine in China. In addition, results from a previous study suggested very low awareness and acceptability of HPV vaccine among MSM in China, in which only 18.4% of MSM had heard of HPV, 10.2% had heard of HPV vaccine, and 20.2% were willing to take HPV vaccine before sexual debut \[[@pone.0187928.ref030]\]. Joint efforts should be made by MSM media and MSM community organizations and clinicians to enhance health education about HPV vaccination among MSM at proper age.

Risk factors associated with any anal HPV infection among MSM were various in previous studies. The most consistently reported risk factors for anal HPV infection were a past history of receptive anal intercourse, recent receptive anal intercourse and a higher number of male sexual partners in the past months \[[@pone.0187928.ref031]--[@pone.0187928.ref034]\]. Similarly, receptive anal intercourse in the past year was associated with anal HPV infection in our study. However, frequency of condom use during homosexual behaviors in the past six month and number of male sexual partners in the past six month were not associated with any anal HPV infection among MSM in our study. Results for these associations were not consistent in previous studies either \[[@pone.0187928.ref003], [@pone.0187928.ref034], [@pone.0187928.ref035]--[@pone.0187928.ref036]\]. Importantly, HPV transmission can occur through other non-intercourse anal sexual practices such as fingering, fisting and oral sex \[[@pone.0187928.ref037]\], this may partially explain why the association of frequency of condom use during homosexual behaviors with anal HPV infection was not observed in our study. Racial difference in anal HPV infection among MSM was observed in several studies \[[@pone.0187928.ref009], [@pone.0187928.ref031]\]. In our study, we found other ethnic minority groups were more likely to have anal HPV infection compared to Han ethnic group after adjustment of potential confounders, although this association was marginal (*p* = 0.072). This marginal racial disparity may be real or due to recruitment of a small number of ethnic minorities in our study. 25% of the total population of Urumqi city are ethnic minorities (2016 Statistical Yearbook of Xinjiang Uyghur Autonomous Region, China), and majority of them are Muslim. Recruitment of Muslim MSM participant in scientific studies is quite difficult because MSM of Muslim background often conceal their homosexual identity to avoid harsh stigma and discrimination by Islamic society \[[@pone.0187928.ref038], [@pone.0187928.ref039]\]. MSM with different religious belief and those irreligious may differ in homosexual behaviors, and religiosity may play an important role in transmission of infectious disease among MSM in China \[[@pone.0187928.ref040]\]. Future study should be done among Muslim MSM in Xinjiang region to investigate the real prevalence and risk factors of HPV infection among them.

The results in our study should be interpreted with caution. First, due to the nature of convenience sampling and source of recruitment, participants in our study may not represent all MSM in Urumqi city. This may lead to selection bias in our study. Second, cross-sectional detection of HPV may be transient deposition only, thus it is difficult to predict how many of the cases would persist. Third, we used interviewer-based questionnaire rather than self-administered questionnaire, this may introduce some information bias given the sensitivity of the topic (e.g. selective reporting of sexual behavior/habits due to prejudice/stigma, etc.). Fourth, HIV-positive MSM were not included in our study due to very low prevalence of HIV infection in our sample. Future HPV prevalence study should be focused on HIV-positive MSM in Xinjiang province.

Conclusions {#sec017}
===========

In conclusion, high prevalence of any anal HPV infection (51.8%) and any HR-HPV infection (38.0%) was observed among HIV-negative MSM in Urumqi city. The most prevalent HPV genotype was HPV 6, followed by HPV 16, HPV 11, HPV 51 and HPV 18, most of which were covered by quadrivalent and 9-valent HPV vaccine. Receptive anal intercourse in the past year was the only risk factor associated with any anal HPV infection in our study population. Regular anal exams and early HPV vaccination among MSM may be considered in future HPV prevention programs in Xinjiang, China.
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